Maria A Rocca
Maria A Rocca is an expert in Neurology at IRCCS Ospedale San Raffaele (Italy). As of October 2026, ScienceLeadR ranks Maria A Rocca in the top 1% of experts worldwide for Multiple Sclerosis, Autoimmune Diseases and Cognitive Dysfunction. Maria A Rocca has authored 1,006 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 4 of them ongoing. SLR score: 3,694 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Immunology - Internal Medicine - Psychiatry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 1006
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study). PMID 42400474 — registries, sclerosis, multiple sclerosis, safety, incidence, central nervous system diseases, neoplasms, drug therapy, drug-related side effects and adverse reactions, antibodies, monoclonal, therapeutics, infections | Mult Scler | 2026 | 0 |
| Neural stem cell transplantation in progressive multiple sclerosis: STEMS study long-term outcomes. PMID 42897668 — cells, sclerosis, multiple sclerosis, neural stem cells, safety, microscopy, electron, scanning transmission, atrophy, brain, stem cells, biomarkers, cell transplantation, stem cell transplantation, transplantation, cognition | Stem Cell Res Ther | 2026 | 0 |
| Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD. PMID 42900856 — sclerosis, multiple sclerosis, atrophy, brain, neuromyelitis optica, demyelinating diseases, third ventricle, tissues, wounds and injuries, neurology | Neurology | 2026 | 0 |
| Clinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry. PMID 42881253 — registries, antibodies, myelitis, phenotype, neurosurgery, neuromyelitis optica, rituximab, antibodies, monoclonal, sex, therapeutics, neurology | J Neurol | 2026 | 0 |
| Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry. PMID 42873203 — registries, sclerosis, multiple sclerosis, intelligence, research, therapeutics, artificial intelligence, generative artificial intelligence | Mult Scler | 2026 | 0 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder a Study to Assess Disease Activity in Apparently Stable Patients NCT07526298 — cells, bioengineering, blood, immunologic factors, biomarkers, neuromyelitis optica, research | N/A | Not yet recruiting | 2026 |
| Validation of the Consecutive Letter Substitution Task (CST) NCT06066281 — neuropsychological tests, healthy volunteers | N/A | Recruiting | 2023 |
| Preventing the Progression of Multiple Sclerosis Early Rehabilitative Treatment and Multimodal Assessment Part A NCT06219291 — exercise, sclerosis, multiple sclerosis, brain, disease progression, wearable electronic devices, therapeutics, prognosis | N/A | Enrolling by invitation | 2022 |
| Home based Action Observation Treatment With Virtual reality for Arm Rehabilitation in People With Multiple Sclerosis NCT05713890 — eye, sclerosis, virtual reality, multiple sclerosis, activities of daily living, imagery, psychotherapy, neuroimaging, imagination, rehabilitation, therapeutics | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map